Antibacterial activity of a novel peptide-modified lysin against Acinetobacter baumannii and Pseudomonas aeruginosa

Frontiers in Microbiology

Volumn 6, Issue DEC, 2015, Pages

  Yang, Hang ^a   Wang, Mengyue ^a   Yu, Junping ^a   Wei, Hongping ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Acinetobacter baumannii; Bacteriophage lysin; Engineered lysin; Outer membrane permeabilizers (OMPs); Pseudomonas aeruginosa

Indexed keywords

PEPTIDE MODIFIED LYSIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL OUTER MEMBRANE; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFORMATION; MILK; NONHUMAN; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84954237133     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01471     Document Type: Article

References (29)

1. Bassetti, M., Villa, G., and Pecori, D. (2014). Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation. Future Microbiol. 9, 465-474. doi: 10.2217/fmb.14.7.
2. Briers, Y., Cornelissen, A., Aertsen, A., Hertveldt, K., Michiels, C. W., Volckaert, G., et al. (2008). Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure. FEMS Microbiol. Lett. 280, 113-119. doi: 10.1111/j.1574-6968.2007.01051.x.
3. Briers, Y., and Lavigne, R. (2015). Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria. Future Microbiol. 10, 377-390. doi: 10.2217/fmb.15.8.
4. Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C. W., Hertveldt, K., et al. (2007). Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Mol. Microbiol. 65, 1334-1344. doi: 10.1111/j.1365-2958.2007.05870.x.
5. Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J. P., Defraine, V., et al. (2014a). Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58, 3774-3784. doi: 10.1128/AAC.02668-14.
6. Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., et al. (2014b). Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens. MBio 5:e1379-14. doi: 10.1128/mBio.01379-14.
7. Briers, Y., Walmagh, M., and Lavigne, R. (2011). Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. J. Appl. Microbiol. 110, 778-785. doi: 10.1111/j.1365-2672.2010.04931.x.
8. Cronan, J. E. Jr. (1978). Molecular biology of bacterial membrane lipids. Annu. Rev. Biochem. 47, 163-189. doi: 10.1146/annurev.bi.47.070178.001115.
9. Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. J., and Fischetti, V. A. (2010). Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 1603-1612. doi: 10.1128/AAC.01625-09.
10. Fischbach, M. A., and Walsh, C. T. (2009). Antibiotics for emerging pathogens. Science 325, 1089-1093. doi: 10.1126/science.1176667.
11. Fischetti, V. A. (2008). Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11, 393-400. doi: 10.1016/j.mib.2008.09.012.
12. Garcia-Quintanilla, M., Pulido, M. R., Lopez-Rojas, R., Pachon, J., and Mcconnell, M. J. (2013). Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol. 21, 157-163. doi: 10.1016/j.tim.2012.12.002.
13. Huang, Y., Yang, H., Yu, J., and Wei, H. (2015). Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity. Virol. Sin. 30, 45-51. doi: 10.1007/s12250-014-3535-6.
14. Knoll, B. M., and Mylonakis, E. (2014). Antibacterial bioagents based on principles of bacteriophage biology: an overview. Clin. Infect. Dis. 58, 528-534. doi: 10.1093/cid/cit771.
15. Lai, M. J., Lin, N. T., Hu, A., Soo, P. C., Chen, L. K., Chen, L. H., et al. (2011). Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl. Microbiol. Biotechnol. 90, 529-539. doi: 10.1007/s00253-011-3104-y.
16. Li, X. Z., Plesiat, P., and Nikaido, H. (2015). The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337-418. doi: 10.1128/CMR.00117-14.
17. Lim, J. A., Shin, H., Heu, S., and Ryu, S. (2014). Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria. J. Microbiol. Biotechnol. 24, 803-811.
18. Livermore, D. M., and Woodford, N. (2006). The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14, 413-420. doi: 10.1016/j.tim.2006.07.008.
19. Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., et al. (2015). Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob. Agents Chemother. 59, 1983-1991. doi: 10.1128/AAC.04641-14.
20. Lukacik, P., Barnard, T. J., Keller, P. W., Chaturvedi, K. S., Seddiki, N., Fairman, J. W., et al. (2012). Structural engineering of a phage lysin that targets gram-negative pathogens. Proc. Natl. Acad. Sci. U.S.A. 109, 9857-9862. doi: 10.1073/pnas.1203472109.
21. Morita, M., Tanji, Y., Orito, Y., Mizoguchi, K., Soejima, A., and Unno, H. (2001). Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett. 500, 56-59. doi: 10.1016/S0014-5793(01)02587-X.
22. Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., et al. (2012). Endolysins as antimicrobials. Adv. Virus Res. 83, 299-365. doi: 10.1016/B978-0-12-394438-2.00007-4.
23. Oliveira, H., Thiagarajan, V., Walmagh, M., Sillankorva, S., Lavigne, R., Neves-Petersen, M. T., et al. (2014). A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acids. PLoS ONE 9:e108376. doi: 10.1371/journal.pone.0108376.
24. Pastagia, M., Schuch, R., Fischetti, V. A., and Huang, D. B. (2013). Lysins: the arrival of pathogen-directed anti-infectives. J. Med. Microbiol. 62, 1506-1516. doi: 10.1099/jmm.0.061028-0.
25. Potron, A., Poirel, L., and Nordmann, P. (2015). Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int. J. Antimicrob. Agents 45, 568-585. doi: 10.1016/j.ijantimicag.2015.03.001.
26. Silvestro, L., and Axelsen, P. H. (2000). Membrane-induced folding of cecropin A. Biophys. J. 79, 1465-1477. doi: 10.1016/S0006-3495(00)76398-3.
27. Walmagh, M., Briers, Y., Dos Santos, S. B., Azeredo, J., and Lavigne, R. (2012). Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201phi2-1 and PVP-SE1. PLoS ONE 7:e36991. doi: 10.1371/journal.pone.0036991.
28. Yang, H., Wang, D. B., Dong, Q. H., Zhang, Z. P., Cui, Z. Q., Deng, J. Y., et al. (2012). Existence of Separate Domains in Lysin PlyG for Recognizing Bacillus anthracis Spores and Vegetative Cells. Antimicrob. Agents Chemother. 56, 5031-5039. doi: 10.1128/AAC.00891-12.
29. Yang, H., Yu, J., and Wei, H. (2014). Engineered bacteriophage lysins as novel anti-infectives. Front. Microbiol. 5:542. doi: 10.3389/fmicb.2014.00542.